Consolidated Statements of Cash Flows (Predecessor Basis) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations			$ (9,667,137)	$ 1,598,430
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash from operating activities:
Proceeds from sale of investments, net			5,204,853	6,324,865
Return of capital			11,486,835	12,814,896
Purchase of investments			(12,685,590)	(25,994,956)
Net realized gains on investments	$ 26	$ (1,301,005)	(1,016,326)	(1,410,019)
Net unrealized loss on investments	6,959,547	2,294,778	10,135,612	1,238,004
Amortization of deferred offering costs			342,015	640,208
Changes in assets and liabilities:
Investment income, rent and other receivable			(447,398)	1,577,347
Due from related entities			(150,866)	0
Other assets			65,129	(76,965)
Payment of deferred offering costs			(36,578)	(497,374)
Accounts payable and accrued liabilities			(48,028)	(139,296)
Due to related entities			(40,083)	(1,768,932)
Net cash from operating activities			3,142,438	(5,693,792)
Cash flows from investing activities:
Cash acquired through consolidation of subsidiary			1,932,088	0
Net cash from investing activities			1,932,088	0
Cash flows from financing activities:
Proceeds from issuance of common stock			218,439	11,966,284
Redemption of common stock			0	(1,555,685)
Dividends to stockholders			0	(2,231,869)
Payment of selling commissions and fees			(9,107)	(1,114,752)
Change in capital pending acceptance			(87,739)	355,085
Net cash from financing activities			121,593	7,419,063
Net increase in cash and cash equivalents			5,196,119	1,725,271
Cash, cash equivalents and restricted cash at beginning of the period			8,957,393	1,278,668
Cash, cash equivalents and restricted cash at end of the period	14,153,512	3,003,939	14,153,512	3,003,939
Cash and cash equivalents at end of the period	12,539,943	3,003,939	12,539,943	3,003,939
Restricted cash at end of the period	1,613,569	0	1,613,569	0
Non-cash investing and financing activities:
Issuance of common stock through reinvestment of dividends	0	813,102	0	1,629,033
Issuance of the Company's common stocks to redeem subsidiary's non-controlling interests	3,957,115	0	3,957,115	0
Assets:
Real estate assets	30,196,471	0	30,196,471	0
Cash and restricted cash	1,932,088	0	1,932,088	0
Rents and other receivable	197,760	0	197,760	0
Other assets	837,133	0	837,133	0
Liabilities:
Mortgage note payable	23,974,545	0	23,974,545	0
Accounts payable and accrued liabilities	943,805	0	943,805	0
Due to affiliates	150,866	$ 0	150,866	$ 0
Net assets	$ 8,094,236		$ 8,094,236